BAFNAPH.NS

Bafna Pharmaceuticals Limited

NSEHealthcare

₹216.45

▼ -2.00%-₹4.41 today

₹0.00₹0.00

Ask Warren

Open

₹0.00

Prev close

₹220.86

Day range

₹0 – ₹0

52W range

₹78.18 – ₹213.36

Volume

12.2K

Avg vol (20D)

5.7K

Mkt cap

₹512.04Cr

P/E TTM

46.3×

Trade Bafna Pharmaceuticals Limited with Artha

Company Metrics

Revenue (ttm)₹150.62 Cr

Net Income (ttm)₹0.00

Shares Out2.37 Cr

EPS (ttm)

Forward PE

Dividend

Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.08

About BAFNAPH.NS

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

Employees0

Stock ExchangeNSE

Ticker SymbolBAFNAPH.NS

Websitehttps://www.bafnapharma.com

BAFNAPH.NS · NSE

Financial Performance

In 2026, Bafna Pharmaceuticals Limited's revenue was ₹150.62 Cr, an increase of +8.10% compared to the previous year. Earnings were ₹0.00, an increase of +111.00%.

Revenue (2026)

₹150.62 Cr

↗+8.10% YoY

Earnings (2026)

₹0.00

↗+111.00% YoY

Year-over-Year Growth

Revenue

+8.10%

Earnings

+111.00%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account